跳至主要内容
临床试验/CTRI/2020/10/028581
CTRI/2020/10/028581尚未招募未知

Inhalation Budesonide in the treatment of patients with mild Covid-19

Dr Tushar Patel0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient with RT-PCR OR Rapid Antigen confirmed diagnosis of Covid-19.
  • asymptomatic Patent with mild symptoms of less than 5 days duration.
  • 3.Spo2 >94% at room air.
  • 4.No Radiological evidence of Pneumonia.
  • 5 Patient aged >18years to 99Years.

排除标准

  • 1. Patient requiring hospitaisation.
  • 2. Patient unable to take the drug as drirected and comply with study procedure.
  • 3.Vulnerable population(Pregnant women,Lactating women,Prisoners,Unable to consent).
  • 4 Patients on Systemic/Inhalational Steroids.

研究者

发起方
Dr Tushar Patel

相似试验